Cargando…

A novel compound heterozygous mutation in TREM2 found in a Turkish frontotemporal dementia-like family()

Triggering receptor expressed on myeloid cells 2 (TREM2) homozygous mutations cause Nasu-Hakola disease, an early-onset recessive form of dementia preceded by bone cysts and fractures. The same type of mutations has recently been shown to cause frontotemporal dementia (FTD) without the presence of a...

Descripción completa

Detalles Bibliográficos
Autores principales: Guerreiro, Rita, Bilgic, Basar, Guven, Gamze, Brás, José, Rohrer, Jonathan, Lohmann, Ebba, Hanagasi, Hasmet, Gurvit, Hakan, Emre, Murat
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3898264/
https://www.ncbi.nlm.nih.gov/pubmed/23870839
http://dx.doi.org/10.1016/j.neurobiolaging.2013.06.005
_version_ 1782300394319249408
author Guerreiro, Rita
Bilgic, Basar
Guven, Gamze
Brás, José
Rohrer, Jonathan
Lohmann, Ebba
Hanagasi, Hasmet
Gurvit, Hakan
Emre, Murat
author_facet Guerreiro, Rita
Bilgic, Basar
Guven, Gamze
Brás, José
Rohrer, Jonathan
Lohmann, Ebba
Hanagasi, Hasmet
Gurvit, Hakan
Emre, Murat
author_sort Guerreiro, Rita
collection PubMed
description Triggering receptor expressed on myeloid cells 2 (TREM2) homozygous mutations cause Nasu-Hakola disease, an early-onset recessive form of dementia preceded by bone cysts and fractures. The same type of mutations has recently been shown to cause frontotemporal dementia (FTD) without the presence of any bone phenotype. Here, we further confirm the association of TREM2 mutations with FTD-like phenotypes by reporting the first compound heterozygous mutation in a Turkish family.
format Online
Article
Text
id pubmed-3898264
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-38982642014-01-24 A novel compound heterozygous mutation in TREM2 found in a Turkish frontotemporal dementia-like family() Guerreiro, Rita Bilgic, Basar Guven, Gamze Brás, José Rohrer, Jonathan Lohmann, Ebba Hanagasi, Hasmet Gurvit, Hakan Emre, Murat Neurobiol Aging Genetic Reports Abstract Triggering receptor expressed on myeloid cells 2 (TREM2) homozygous mutations cause Nasu-Hakola disease, an early-onset recessive form of dementia preceded by bone cysts and fractures. The same type of mutations has recently been shown to cause frontotemporal dementia (FTD) without the presence of any bone phenotype. Here, we further confirm the association of TREM2 mutations with FTD-like phenotypes by reporting the first compound heterozygous mutation in a Turkish family. Elsevier 2013-12 /pmc/articles/PMC3898264/ /pubmed/23870839 http://dx.doi.org/10.1016/j.neurobiolaging.2013.06.005 Text en © 2013 The Authors https://creativecommons.org/licenses/by/3.0/ Open Access under CC BY 3.0 (https://creativecommons.org/licenses/by/3.0/) license
spellingShingle Genetic Reports Abstract
Guerreiro, Rita
Bilgic, Basar
Guven, Gamze
Brás, José
Rohrer, Jonathan
Lohmann, Ebba
Hanagasi, Hasmet
Gurvit, Hakan
Emre, Murat
A novel compound heterozygous mutation in TREM2 found in a Turkish frontotemporal dementia-like family()
title A novel compound heterozygous mutation in TREM2 found in a Turkish frontotemporal dementia-like family()
title_full A novel compound heterozygous mutation in TREM2 found in a Turkish frontotemporal dementia-like family()
title_fullStr A novel compound heterozygous mutation in TREM2 found in a Turkish frontotemporal dementia-like family()
title_full_unstemmed A novel compound heterozygous mutation in TREM2 found in a Turkish frontotemporal dementia-like family()
title_short A novel compound heterozygous mutation in TREM2 found in a Turkish frontotemporal dementia-like family()
title_sort novel compound heterozygous mutation in trem2 found in a turkish frontotemporal dementia-like family()
topic Genetic Reports Abstract
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3898264/
https://www.ncbi.nlm.nih.gov/pubmed/23870839
http://dx.doi.org/10.1016/j.neurobiolaging.2013.06.005
work_keys_str_mv AT guerreirorita anovelcompoundheterozygousmutationintrem2foundinaturkishfrontotemporaldementialikefamily
AT bilgicbasar anovelcompoundheterozygousmutationintrem2foundinaturkishfrontotemporaldementialikefamily
AT guvengamze anovelcompoundheterozygousmutationintrem2foundinaturkishfrontotemporaldementialikefamily
AT brasjose anovelcompoundheterozygousmutationintrem2foundinaturkishfrontotemporaldementialikefamily
AT rohrerjonathan anovelcompoundheterozygousmutationintrem2foundinaturkishfrontotemporaldementialikefamily
AT lohmannebba anovelcompoundheterozygousmutationintrem2foundinaturkishfrontotemporaldementialikefamily
AT hanagasihasmet anovelcompoundheterozygousmutationintrem2foundinaturkishfrontotemporaldementialikefamily
AT gurvithakan anovelcompoundheterozygousmutationintrem2foundinaturkishfrontotemporaldementialikefamily
AT emremurat anovelcompoundheterozygousmutationintrem2foundinaturkishfrontotemporaldementialikefamily
AT guerreirorita novelcompoundheterozygousmutationintrem2foundinaturkishfrontotemporaldementialikefamily
AT bilgicbasar novelcompoundheterozygousmutationintrem2foundinaturkishfrontotemporaldementialikefamily
AT guvengamze novelcompoundheterozygousmutationintrem2foundinaturkishfrontotemporaldementialikefamily
AT brasjose novelcompoundheterozygousmutationintrem2foundinaturkishfrontotemporaldementialikefamily
AT rohrerjonathan novelcompoundheterozygousmutationintrem2foundinaturkishfrontotemporaldementialikefamily
AT lohmannebba novelcompoundheterozygousmutationintrem2foundinaturkishfrontotemporaldementialikefamily
AT hanagasihasmet novelcompoundheterozygousmutationintrem2foundinaturkishfrontotemporaldementialikefamily
AT gurvithakan novelcompoundheterozygousmutationintrem2foundinaturkishfrontotemporaldementialikefamily
AT emremurat novelcompoundheterozygousmutationintrem2foundinaturkishfrontotemporaldementialikefamily